Stability and Change in Autism Spectrum Disorder Diagnosis from Age 3 to Middle Childhood in a High-risk Sibling Cohort
Overview
Authors
Affiliations
Considerable evidence on autism spectrum disorder emergence comes from longitudinal high-risk samples (i.e. younger siblings of children with autism spectrum disorder). Diagnostic stability to age 3 is very good when diagnosed as early as 18-24 months, but sensitivity is weaker, and relatively little is known beyond toddlerhood. We examined stability and change in blinded, clinical best-estimate diagnosis from age 3 to middle childhood (mean age = 9.5 years) in 67 high-risk siblings enrolled in infancy. Good agreement emerged for clinical best-estimate diagnoses (89.6% overall; kappa = 0.76, p < 0.001, 95% confidence interval = 0.59-0.93). At age 3, 18 cases (26.9%) were classified with "autism spectrum disorder": 17 retained their autism spectrum disorder diagnosis (94.4%; 13 boys, 4 girls) and 1 no longer met autism spectrum disorder criteria at follow-up. Among "non-autism spectrum disorder" cases at age 3, 43/49 remained non-autism spectrum disorder at follow-up (87.8%; 22 boys, 21 girls) and 6/49 met lower autism symptomatology criteria ("Later-Diagnosed"; 3 boys, 3 girls). Later-diagnosed cases had significantly lower autism spectrum disorder symptomatology and higher receptive language at age 3 and trends toward lower autism symptoms and higher cognitive abilities at follow-up. Emerging developmental concerns were noted in all later-diagnosed cases, by age 3 or 5. High-risk children need to be followed up into middle childhood, particularly when showing differences in autism-related domains.
Schaubroeck S, Demurie E, Begum-Ali J, Bolte S, Boterberg S, Buitelaar J J Autism Dev Disord. 2024; .
PMID: 39397184 DOI: 10.1007/s10803-024-06585-y.
Mid-childhood autism sibling recurrence in infants with a family history of autism.
Bazelmans T, Arthur R, Pasco G, Shephard E, Milosavljevic B, Begum Ali J Autism Res. 2024; 17(7):1501-1514.
PMID: 38973707 PMC: 11801122. DOI: 10.1002/aur.3182.
Eijsbroek V, Kjell K, Schwartz H, Boehnke J, Fried E, Klein D medRxiv. 2024; .
PMID: 38699296 PMC: 11065032. DOI: 10.1101/2024.03.19.24304526.
The influence of loss to follow-up in autism screening research: Taking stock and moving forward.
Sheldrick R, Hooker J, Carter A, Feinberg E, Croen L, Kuhn J J Child Psychol Psychiatry. 2023; 65(5):656-667.
PMID: 37469104 PMC: 10801774. DOI: 10.1111/jcpp.13867.
Segal L, Green J, Twizeyemariya A, Hudry K, Wan M, Barbaro J JAMA Netw Open. 2023; 6(4):e235847.
PMID: 37017966 PMC: 10077097. DOI: 10.1001/jamanetworkopen.2023.5847.